Solo Stemcells Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 138.31%
(FY 2022)
- Profit 227.98%
(FY 2022)
- Ebitda 122.61%
(FY 2022)
- Net Worth 7.19%
(FY 2022)
- Total Assets 12.81%
(FY 2022)
About Solo Stemcells
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunita Tandulwadkar, Rajesh Tandulwadkar, and Rishi Tandulwadkar serve as directors at the Company.
- CIN/LLPIN
U74999PN2016PTC164349
- Company No.
164349
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Solo Stemcells?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishi Tandulwadkar  | Director | 05-May-2016 | Current |
| Rajesh Tandulwadkar | Director | 05-May-2016 | Current |
| Sunita Tandulwadkar | Director | 05-May-2016 | Current |
Financial Performance and Corporate Structure Insights of Solo Stemcells.
Solo Stemcells Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 138.31% increase. The company also saw a substantial improvement in profitability, with a 227.98% increase in profit. The company's net worth moved up by a moderate rise of 7.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solo Stemcells?
In 2022, Solo Stemcells had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Alreschaa Life Sciences LlpActive 5 years 4 months
Sunita Tandulwadkar, Rajesh Tandulwadkar and 1 more are mutual person
- Alreschaa Ventures Private LimitedActive 4 years 5 months
Sunita Tandulwadkar, Rajesh Tandulwadkar and 1 more are mutual person
- Solo Research FoundationActive 8 years 5 months
Sunita Tandulwadkar, Rajesh Tandulwadkar and 1 more are mutual person
- Solo Clinic Private LimitedActive 6 years 8 months
Sunita Tandulwadkar and Rishi Tandulwadkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Solo Stemcells?
Unlock and access historical data on people associated with Solo Stemcells, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solo Stemcells, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solo Stemcells's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
